Generics 47

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Polymyxin b manufacturers

47 products found

Filters

47 products found

polymyxin b

Vials, lyophilized injection 500 000 IU

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA
Comments
Storage conditions: Between 15-25 °C (59-77°F)
Manufacturer #1187
This company specializes in providing critical care therapies and anti-infective treatments for serious and life-threatening infections. They manufacture both Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs), offering a range of products from generics to specialty pharmaceuticals. Their key focus lies in anti-infective treatments, particularly in the areas of oncology and critical care. The company operates across various regions, including Europe, North America, and Asia, with strong manufacturing facilities in the US, China, Denmark, and Hungary. The company is a leading supplier of Vancomycin and Colistimethate Sodium (CMS) and has a track record of over a century in the pharmaceutical industry. They boast state-of-the-art manufacturing sites, robust research and development capabilities, and a commitment to sustainability.

Manufacturer usually replies in 5 days

The only EU CTD dossier on the platform

neomycin + polymyxin b + dexamethasone

Eye drops 3.5 mg/ml + 6000 IU/ml + 1 mg/ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 18 days

neomycin + bacitracin + polymyxin b

Cutaneous powder 3400 IU/g + 600 IU/g + 500 IU/g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15932

A pharmaceutical manufacturer based in the EU that is active in 20+ countries for 20+ years. Key production lines are generic, medical device, OTC, nutraceuticals, and cosmetics. They are produced in GMP-compliant manufacture. Main therapeutic areas include allergology and pulmonology, cardiology, dermatology, and the central nervous system. The main dosage forms are liquid, solid, semi-solid, and sprays.

Manufacturer usually replies in 18 days

Want to see all 47 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Polymyxin B is an antibiotic used to treat bacterial infections, such as meningitis, pneumonia, sepsis. Although manufacturing companies use polymyxin B as a standalone drug, it is more commonly used in combination drug formulations, along with other active ingredients such as lidocaine, neomycin, bacitracin, diperodon, hydrocortisone, as well as many others. Polymyxin B suppliers market the standalone medication in the form of powders for injectable solutions. In medical use for over 50 years, polymyxin B has since become included in the WHO’s list of Essential Medicines that contains the most important drugs recommended for a basic health system. Polymyxin B suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified polymyxin B manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.